Answers are grounded in this paper and cite their sources.
Functional analysis reveals miR-148a-3p as a potential biomarker for diabetic peripheral neuropathy, suggesting early intervention benefits.
Background Type 2 diabetic peripheral neuropathy (T2DM-DPN) not only raises amputation risk but also strains healthcare resources, making the identification of diagnostic biomarkers crucial for early intervention and targeted treatment.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: